Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study have?
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study has 532 citations in the OpenAlex counts ScholarIQ stores.
When was Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study published?
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study has 2021 year in the ScholarIQ index.
What is the open-access status of Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study?
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study has hybrid oa status in the ScholarIQ index.
What is the DOI of Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study?
The DOI for Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study is on the source record.
What is the PMID of Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study?
The PMID for Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study is on the source record.
What is the OpenAlex record for Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study?
The OpenAlex for Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study is on the source record.